Cite
Anti-BlyS antibody reduces the immune reaction against enzyme and enhances the efficacy of enzyme replacement therapy in Fabry disease model mice.
MLA
Sato, Yohei, et al. “Anti-BlyS Antibody Reduces the Immune Reaction against Enzyme and Enhances the Efficacy of Enzyme Replacement Therapy in Fabry Disease Model Mice.” Clinical Immunology (Orlando, Fla.), vol. 178, May 2017, pp. 56–63. EBSCOhost, https://doi.org/10.1016/j.clim.2017.01.014.
APA
Sato, Y., Ida, H., & Ohashi, T. (2017). Anti-BlyS antibody reduces the immune reaction against enzyme and enhances the efficacy of enzyme replacement therapy in Fabry disease model mice. Clinical Immunology (Orlando, Fla.), 178, 56–63. https://doi.org/10.1016/j.clim.2017.01.014
Chicago
Sato, Yohei, Hiroyuki Ida, and Toya Ohashi. 2017. “Anti-BlyS Antibody Reduces the Immune Reaction against Enzyme and Enhances the Efficacy of Enzyme Replacement Therapy in Fabry Disease Model Mice.” Clinical Immunology (Orlando, Fla.) 178 (May): 56–63. doi:10.1016/j.clim.2017.01.014.